Transitional Cell Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder [Phase 2]
Phase 2 preoperative trial of atezolizumab (MPDL3280A) in transitional cell carcinoma of the bladder has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Neoadjuvant Atezolizumab in Localized Bladder Cancer [Phase 2]
Phase 2 neoadjuvant study of atezolizumab in localized bladder cancer has completed, with results posted on May 31, 2024.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2, Phase 3]
Phase 2/3 study evaluating rografatinib (BAY1163877) versus chemotherapy in FGFR-positive urothelial carcinoma; the trial is completed with …
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab [Phase 2]
Phase 2 trial update examining biomarkers in urothelial cancer patients treated with pembrolizumab.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: PF-03446962 in Relapsed or Refractory Urothelial Cancer [Phase 2]
Phase 2 clinical trial of PF-03446962 in relapsed or refractory urothelial cancer (transitional cell carcinoma of the bladder) has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer [Phase 2, Phase 3]
Phase 2/3 trial of recombinant adenovirus for non-muscle invasive bladder cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function [Phase 2]
Phase 2 trial evaluating a combination of gemcitabine, paclitaxel, and doxorubicin in metastatic or unresectable bladder cancer with decreas…
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 open-label dose-finding study evaluated the safety and pharmacokinetics of FPA144 in patients with advanced solid tumors, inclu…
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer [Phase 2]
Phase 2 trial investigating sunitinib malate in recurrent transitional cell bladder cancer has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery [NA]
Terminated trial evaluating broccoli sprout extract in bladder cancer patients undergoing surgery, with results posted in 2016. The study in…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine [Phase 3]
Phase 3 clinical trial update on a laser-based photodynamic detection method for transitional cell carcinoma of the bladder has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder [NA]
This completed Phase II trial evaluated concurrent intravesical Bacillus Calmette-Guérin (BCG) and interferon for treatment and prevention o…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin [Phase 2]
Phase 2 trial comparing gemcitabine versus carboplatin in cisplatin-unfit patients with advanced transitional cell carcinoma of the bladder …
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy [Phase 2, Phase 3]
A completed Phase 2/3 randomized trial in advanced bladder cancer comparing first-line gemcitabine with versus without vinflunine in patient…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluated prostate capsule-sparing cystectomy and nerve-sparing radical cystoprostatectomy in men with bladder canc…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: JAVLOR® Online Non-Interventional Trial
The JAVLOR online non-interventional trial sponsored by Pierre Fabre Pharma GmbH has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium [Phase 2]
A Phase 2 trial of Vorinostat for locally recurrent or metastatic urothelial cancers was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder [Phase 2]
This document reports the results of a Phase 2 trial evaluating the combination of paclitaxel, carboplatin, and gemcitabine in patients with…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Intravesical Adjuvant Electromotive Mitomycin-C [Phase 2, Phase 3]
Clinical trial update announcing completion of Phase 2/3 evaluation of intravesical adjuvant electromotive delivery of mitomycin-C for bladd…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma [Phase 2]
This ClinicalTrials.gov entry reports a Phase II study of bortezomib (PS-341) in patients with previously treated advanced urothelial tract …
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder [Phase 2]
This entry summarizes a completed Phase 2 trial evaluating robotic-assisted laparoscopic extended pelvic lymph node dissection for transitio…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial of ixabepilone in advanced urinary tract cancers has completed, evaluating its activity across several urothelial and…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Gene Therapy in Treating Patients With Advanced Bladder Cancer [Phase 1]
Phase 1 gene therapy trial update for advanced bladder cancer has completed, including patients with recurrent and various stages of the dis…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab with chemotherapy in locally recurrent or metastatic urinary tract cancers has completed, incl…
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder [Phase 2]
A Phase 2 study evaluating pralatrexate for advanced or metastatic relapsed transitional cell carcinoma of the urinary bladder has completed…